Marinomed Biotech Announces Capital increase with subscription rights
EQS-Media / 19.03.2026 / 16:47 CET/CEST
Marinomed Biotech Announces Capital increase with subscription rights
• Corporate action to meet short-term capital requirements
• Corporate action supported by an institutional investor
• Public shareholders have the opportunity to participate in the capital
increase through subscription rights
• Preliminary figures for 2025
Korneuburg, Austria, March 19, 2026 Marinomed Biotech AG ("Company") has
decided, due to a short-term need for capital, to increase its share
capital!-->…